PradaxaTM has been linked to excessive internal bleeding and heart attacks. In January of 2012, the manufacturer of Pradaxa confirmed at least 260 deaths.
Patients with atrial fibrillation (AF) should not stop taking Pradaxa before speaking with their healthcare professionals. Stopping use of blood thinning medication can increase the risk of strokes.
In October 2010 the FDA approved Pradaxa to help prevent strokes in patients with non-valvular atrial fibrillation. The FDA is now investigating reports of potentially fatal bleeding events and deaths in patients taking Pradaxa.
If you or a loved one suffered or continues to suffer from complications due to Pradaxa, our experienced attorneys are here to help. Please call or submit the form today to determine your next step during this difficult time.
When entrusting your claim to Freese & Goss, you gain a partner with an established record of courtroom success. Our advocacy has consistently resulted in fair and just compensation for our clients. We handle every case with meticulous attention and care and building a robust legal strategy.
If you need any legal support or advice or an advocate by your side, please feel free to contact us without any hesitation. We are committed to giving you your legal rights. Please call or submit an online request for a free, no-obligation consultation.
